Health care systems increasingly allowing patients to rate doctors
Indiana University Health and Community Health Network have joined the national trend of posting online reviews, in a quest to win prospective patients and boost transparency.
Health Care & Life Sciences
Articles
Lilly wins national award for advancing women in the workplace
The Catalyst Award recognizes companies that excel in addressing recruitment, development and advancement of women. Today, nearly half of Lilly's senior leadership is female, up from 20 percent four years ago.
Fast-growing Activate Healthcare acquired by Denver firm
The Indianapolis-based provider of health clinics for businesses has grown to 250 employees in 10 years. But it recently started looking for another owner.
Senators ask FDA to update rules on CBD, hemp products
Congress legalized the production and sale of industrial hemp and hemp derivatives, including CBD. But FDA Commissioner Scott Gottlieb has restated his agency’s stance that CBD is a drug ingredient and therefore illegal to add to food or health products without his agency’s approval.
Walmart to leave CVS pharmacy network
The dispute between the world’s largest retail chain and the prominent pharmacy-benefits manager could roil the business of filling prescriptions.
Disgraced nursing-home CEO wants felony convictions tossed
The ringleader in one of the largest corporate-fraud cases in Indiana in recent years says his legal team at Barnes & Thornburg failed to disclose a “profound conflict of interest.
Local hospitals beginning temporary restrictions for visitors
Indianapolis hospitals are among those in the state imposing restrictions on visitors to try to curb the spread of flu.
Would-be dealmakers warn of M&A, IPO delays due to shutdown
A prolonged shutdown could muddle Eli Lilly and Co.’s plan to unload its stake in Elanco Animal Health Inc., the unit it spun off last year, Lilly CEO Dave Ricks said.
U.S. cancer death rate hits 25th year of decline
Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also are having a positive impact, experts say.
In its biggest takeover ever, Lilly buying cancer drug startup for $8 billion
Connecticut-based Loxo Oncology, which was founded in 2013 and went public a year later, has a cancer drug in development that recently received U.S. Food and Drug Administration "breakthrough therapy" status.
In one of biggest pharma deals ever, Bristol-Myers Squibb to buy biotech firm for $74B
Bristol-Myers and Celgene combined will have nine products with more than $1 billion in annual sales and significant potential for growth in the core disease areas of oncology, immunology and cardiovascular disease.
Anthem among health care stocks suffering after Obamacare ruling
While many analysts expect the ruling to be reversed by higher courts, the news adds to volatility in a sector that had barely recovered from political static this year.
Nursing homes start facing pinch of penalties for hospital readmissions
The penalties will be as much as 2 percent of Medicare reimbursements, and could be worth millions of dollars to large nursing-home chains with locations spread across Indiana and the nation.
IU Health People Mover train to shut down indefinitely
The health system said the 15-year-old elevated train service needs major maintenance, but did not say whether the system would ever return to service.
Entrepreneur finds financial success with deep-tissue therapy
Entrepreneur Michael Arnolt teamed with an inventor more than 20 years ago to launch an enterprise that has sold thousands of steel therapy instruments and trained thousands of clinicians.
After years of effort, 16 Tech innovation district finally starting construction
Developers of 16 Tech—a consortium of offices, laboratories, housing and retail space—believe the campus will become a powerful economic engine by fostering collaboration and innovation.
Trump Medicare plan targets drugs from Eli Lilly, others
Makers of antidepressants and antipsychotics like Indianapolis-based Eli Lilly and Co., AstraZeneca, Pfizer, Allergan, Bausch Health and Otsuka Holdings might face new challenges and may be deterred from price hikes.
Riley Children’s Foundation announces $175 million campaign
It’s the foundation’s first capital campaign since 2010, when it raised $200 million. The money will be used for pediatric research, patient care, maternity and newborn health, and family support programs.
FDA plans overhaul of medical device approval system
The decades-old system has long been criticized by experts for failing to catch problems with risky implants and medical instruments.
Opioid war rages on, but those on the front lines see progress
The crisis has been years in the making, and the job of wrestling it to the ground has grown into a massive task. No one is yet predicting when the state will be able to declare victory.